Viewing Study NCT00776503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-29 @ 1:06 PM
Study NCT ID: NCT00776503
Status: COMPLETED
Last Update Posted: 2014-03-20
First Post: 2008-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module